Pharmaceutical

Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025

LEXINGTON, Mass., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences…

10 months ago

BioAge Labs to Participate in TD Cowen’s 45th Annual Health Care Conference

RICHMOND, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- BioAge Labs (Nasdaq: BIOA) (“BioAge”, “the Company”), a clinical-stage biopharmaceutical company developing…

10 months ago

Phoenix Molecular Designs Dosed First Patient in Dauntless-1, a Phase 2 Clinical Trial of PMD-026 in Combination with Fulvestrant for RSK2-high Breast Cancer

Phoenix Molecular Designs Infographic Introduction to PhoenixMD PMD-026 is a first-in-class and best-in-class pan-RSK inhibitorFavorable mPFS demonstrated in Phase 1/1b…

10 months ago

Software Effective Solutions Corp. / MedCana (OTC: SFWJ) Announces Milestone Achievement

AUSTIN, Texas, Feb. 20, 2025 /PRNewswire/ -- MedCana (OTC: SFWJ), a leading global infrastructure holding company focused on the pharmaceutical-grade…

10 months ago

SCbio 2025 Conference Showcases the Future of Life Sciences in South Carolina

SCbio unveils new campaign and industry pillars igniting growth in South Carolina's thriving life sciences ecosystem CHARLESTON, S.C., Feb. 20,…

10 months ago

DistillerSR Integrates with RightFind Enterprise to Enable the Purchase of Scientific References Through its Evidence Management Platform

DistillerSR Customers Can Now Search for and Purchase Content Directly from CCC's Proprietary Bibliographic Database of More Than 165 million…

10 months ago

Iktos Secures Prestigious EIC Accelerator Grant to Advance its Automated AI and Robotics Platform for Drug Discovery

PARIS, Feb. 20, 2025 /PRNewswire/ -- Iktos, a global leader in AI-driven drug discovery, has secured a prestigious €2.5 million…

10 months ago

Biofidelity to launch Enspyre® technology at AGBT 2025

Enspyre is a next generation sequencing (NGS) preparation technology enabling higher sensitivity variant calling from a fraction of the data…

10 months ago

Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation ‘Agnostic Diagnostics’ for Respiratory Viruses at the Point of Care

International consortium to develop rapid metagenomic NGS solutions that can identify known and novel respiratory pathogens, reduce time-to-diagnosis, and enhance…

10 months ago

TCBP CEO Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO Forum

EDINBURGH, Scotland , Feb. 20, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) , a clinical-stage…

10 months ago